Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Wixom, Michigan
- Most recent report
- 8-K, filed Nov 3, 2026
- Incorporated
- Delaware
- Filings on record
- 1,000+ filings
- On EDGAR
- CIK 1041024
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Smaller reporting company
Financials 8 of 71
News 8 of 245
- 8-K Significant contract Nov 3, 2026
- 8-K Current report on a material event Aug 13, 2026
- 8-K Quarterly results Aug 13, 2026
- 8-K Other events Jul 20, 2026
- 8-K Current report on a material event Jun 29, 2026
- 8-K Shareholder vote results Jun 15, 2026
- 8-K Current report on a material event May 8, 2026
- 8-K Current report on a material event May 7, 2026
Prospectuses and Registrations 8 of 48
- S-8 Registration statement for an employee plan Aug 14, 2025
- 424B5 Prospectus supplement for an offering Nov 13, 2024
- S-8 Registration statement for an employee plan Oct 8, 2024
- S-3 Shelf registration statement Oct 8, 2024
- S-8 Registration statement for an employee plan Aug 15, 2023
- S-3 Shelf registration statement Aug 15, 2023
- S-8 Registration statement for an employee plan Aug 16, 2022
- 424B5 Prospectus supplement for an offering Jul 26, 2022
Proxies 8 of 47
- DEFA14A Extra proxy material May 11, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 30, 2026
- PRE 14A Preliminary proxy statement Apr 20, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 14, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 15, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 17, 2023
- DEF 14A Proxy statement for a shareholder vote Apr 8, 2022
- PRE 14A Preliminary proxy statement Mar 21, 2022
Ownership 8 of 489
- 4 Insider reported a trade Oct 5, 2026
- 144 Notice of a proposed sale of restricted stock Oct 1, 2026
- 4 Insider reported a trade Jul 6, 2026
- 4 Insider reported a trade Jul 6, 2026
- 4 Insider reported a trade Jul 6, 2026
- 4 Insider reported a trade Jul 6, 2026
- 4 Insider reported a trade Jul 6, 2026
- 4 Insider reported a trade Jul 6, 2026
Other 8 of 100
- ARS Annual report sent to shareholders Apr 30, 2026
- ARS Annual report sent to shareholders Apr 14, 2025
- EFFECT Notice that a registration became effective Oct 21, 2024
- CORRESP Reply to SEC staff Oct 17, 2024
- CORRESP Reply to SEC staff Oct 17, 2024
- UPLOAD Comment letter from SEC staff Oct 15, 2024
- ARS Annual report sent to shareholders Apr 15, 2024
- EFFECT Notice that a registration became effective Aug 22, 2023
Everything here comes from Rockwell Medical, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.